This is episode 2 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).

In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. Colleen Tewksbury to discuss:

• A deep dive into dietary approaches for obesity management including debating low carb versus low fat diets.

• Misconceptions that society has about dietary approaches to weight loss.

• The importance of an individualized approach versus a cure-all for everyone.

To collect CME credit for listening, visit agau.gastro.org.

This is episode 1 of 6 from our new program: Obesity in GI Care: Start the Conversation, Change the Narrative. Over the course of 6 podcast episodes and 3 webinars, you'll learn a comprehensive approach to diagnosing and treating obesity, with a specific focus on patients with GI comorbidities. This series highlights key findings and strategies from AGA’s 2017 Practice guide on Obesity and Weight management, Education and Resources (POWER program).

In this episode, our hosts Drs. Andres Acosta and Octavia Pickett-Blakely are joined by Dr. Naresh Gunaratnam to discuss:

• Weight management is proven to be beneficial in patients with comorbid gastrointestinal (GI) diseases, such as nonalcoholic fatty liver disease (NAFLD), reflux esophagitis, gastrointestinal reflux disease (GERD), gallbladder disease, pancreatitis, esophageal and colon cancer.

• Gastroenterologists and the GI care team are poised to offer comprehensive care for patients with obesity who may require endoscopic procedures and/or bariatric surgery to achieve long term weight loss.

To collect CME credit for listening, visit agau.gastro.org.

This is episode 1 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care talk about the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook. We start with a discussion on the prevalence of NAFLD and NASH and their clinical and economic burdens with guest Zobair Younossi, MD, president, medicine service line, Inova Health System.

To collect CME credit for listening, visit nash.gastro.org.

Lee Kaplan, MD, founding director of the Weight Center at Massachusetts General Hospital, discusses the relationship between NASH, obesity and associated comorbidities.

This is episode 2 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.

To collect CME credit for listening, visit nash.gastro.org.

Kim Pfotenhauer, DO, Michigan State University, and Eugene Wright, MD, Duke University, discuss screening people for NAFLD in the primary care setting.

This is episode 3 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.

To collect CME credit for listening, visit nash.gastro.org.

Vincent Wong, MD, The Chinese University of Hong Kong, provides insights into noninvasive diagnostic techniques for patients at high risk for NASH and the role of liver biopsy in diagnosing NASH.

This is episode 4 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.

To collect CME credit for listening, visit nash.gastro.org.

Robert H. Eckel, MD, University of Colorado, discusses limitations in current data about managing NAFLD and NASH and emerging therapies.

This is episode 5 of our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.

To collect CME credit for listening, visit nash.gastro.org.

We close out this series chatting with Hashem El-Serag, MD, Baylor College of Medicine, about collaboration between primary care providers and specialists in managing patients with NAFLD and NASH.

This is the final episode in our 6-part podcast, NASH: Take Action!, where leaders in gastroenterology, hepatology, endocrinology and primary care discuss the real-world, practical implications of screening, diagnosing and managing people with NAFLD and NASH. This series is hosted by Drs. Fasiha Kanwal, Kenneth Cusi and Jay H. Shubrook.

To collect CME credit for listening, visit nash.gastro.org.

The NASH: Take Action! six-episode podcast series features interviews with world-renowned experts in NAFLD, NASH and metabolic syndrome providing practical information for health care professionals on screening, diagnosing and managing these conditions. Collect up to 6 AMA PRA Category 1 credits for this activity by visiting nash.gastro.org.